ANFOE 10,000IU Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders and in those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood.
ANFOE 6000 IU Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders and in those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood.
ANFOE 4000IU Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders and in those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood.
ANFOE 2000IU Injection belongs to the group of hormones used in the treatment of chronic anaemia and anaemic states seen in kidney disease, cancers, patients on chemotherapy, bone marrow disorders and in those due to undergo major bone surgery. Anaemia refers to low blood counts due to a deficiency of blood component haemoglobin, resulting in a reduced oxygen-carrying capacity of the blood.
Actorise 100mcg Injection is a prescription medication widely used in the treatment of anemia, particularly in patients suffering from chronic kidney disease (CKD) or undergoing chemotherapy. Manufactured by Cipla, Actorise injection contains darbepoetin alfa, a synthetic version of erythropoietin, a hormone responsible for stimulating red blood cell production. Its importance in clinical settings stems from its ability to improve hemoglobin levels, reduce the need for blood transfusions, and enhance the overall quality of life in anemic patients.
Darbecon 40mcg Syringe is a prescription medication that delivers darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells in the body. It plays a crucial role in the treatment of anemia, particularly in patients undergoing chemotherapy or suffering from chronic kidney disease. By enhancing red blood cell production, Darbecon 40mcg Syringe helps improve oxygen delivery to tissues, enhancing energy levels and overall well-being.
